144 related articles for article (PubMed ID: 36881071)
1. Albumin-derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study.
Nakazawa N; Sohda M; Tateno K; Watanabe T; Kimura A; Kogure N; Hosaka H; Naganuma A; Sekiguchi M; Saito K; Ogata K; Sano A; Sakai M; Ogawa H; Shirabe K; Saeki H
In Vivo; 2023; 37(2):818-824. PubMed ID: 36881071
[TBL] [Abstract][Full Text] [Related]
2. Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
Nakanishi T; Matsuda T; Yamashita K; Hasegawa H; Sawada R; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
Anticancer Res; 2024 Jan; 44(1):229-237. PubMed ID: 38159989
[TBL] [Abstract][Full Text] [Related]
3. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.
Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
Ann Surg Oncol; 2022 Apr; 29(4):2663-2671. PubMed ID: 34807322
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Pan Z; Wang Y; Li S; Cai H; Guan G
Biomol Biomed; 2024 May; 24(3):612-624. PubMed ID: 38041687
[TBL] [Abstract][Full Text] [Related]
5. The association between albumin-dNLR score and disease activity in patients with rheumatoid arthritis.
Chen S; Ying H; Du J; Zhu X; Shi J; Zhang Y; Chen S; Shen B; Li J
J Clin Lab Anal; 2019 Mar; 33(3):e22695. PubMed ID: 30320486
[TBL] [Abstract][Full Text] [Related]
6. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
7. Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study.
Nakazawa N; Sohda M; Tateno K; Watanabe T; Kimura A; Kogure N; Hosaka H; Naganuma A; Sekiguchi M; Saito K; Ogata K; Sano A; Sakai M; Ogawa H; Shirabe K; Saeki H
Anticancer Res; 2023 Feb; 43(2):927-934. PubMed ID: 36697068
[TBL] [Abstract][Full Text] [Related]
8. Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma.
Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Kakeji Y
Ann Surg Oncol; 2022 Oct; 29(11):6860-6866. PubMed ID: 35622180
[TBL] [Abstract][Full Text] [Related]
9. An Elevated Serum Lactate Dehydrogenase-to-albumin Ratio Is a Useful Poor Prognostic Predictor of Nivolumab in Patients With Gastric Cancer.
Nakazawa N; Sohda M; Yamaguchi A; Watanabe T; Saito H; Ubukata Y; Kuriyama K; Sano A; Sakai M; Yokobori T; Ogawa H; Shirabe K; Saeki H
Anticancer Res; 2021 Aug; 41(8):3925-3931. PubMed ID: 34281855
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
Tokumaru S; Koizumi T; Sekino Y; Takeuchi N; Nakata S; Miyagawa Y; Kitazawa M; Muranaka F; Nakamura S; Koyama M; Yamamoto Y; Ehara T; Hondo N; Soejima Y
Oncology; 2021; 99(10):632-640. PubMed ID: 34280933
[TBL] [Abstract][Full Text] [Related]
11. Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study.
Nakazawa N; Sohda M; Ubukata Y; Kuriyama K; Kimura A; Kogure N; Hosaka H; Naganuma A; Sekiguchi M; Saito K; Ogata K; Sano A; Sakai M; Ogawa H; Shirabe K; Saeki H
Ann Surg Oncol; 2022 Nov; 29(12):7400-7406. PubMed ID: 35857197
[TBL] [Abstract][Full Text] [Related]
12. Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer.
Liu JX; Li A; Zhou LY; Liu XF; Wei ZH; Wang XZ; Ying HQ
Future Oncol; 2018 Feb; 14(3):229-239. PubMed ID: 29338337
[TBL] [Abstract][Full Text] [Related]
13. Chronological Changes in Neutrophil/lymphocyte Ratio in Advanced Gastric Cancer Patients Treated with Nivolumab: a Report of Nine Cases.
Nakamura N; Kinami S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Takamura H; Ueda N; Kosaka T
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2955-2960. PubMed ID: 33112554
[TBL] [Abstract][Full Text] [Related]
14. Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
Alessi JV; Ricciuti B; Alden SL; Bertram AA; Lin JJ; Sakhi M; Nishino M; Vaz VR; Lindsay J; Turner MM; Pfaff K; Sharma B; Felt KD; Rodig SJ; Gainor JF; Awad MM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824161
[TBL] [Abstract][Full Text] [Related]
15. A Composite Biomarker of Derived Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies.
Pan Y; Si H; Deng G; Chen S; Zhang N; Zhou Q; Wang Z; Dai G
Front Oncol; 2021; 11():798415. PubMed ID: 35251952
[TBL] [Abstract][Full Text] [Related]
16. ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention.
Xiu WJ; Yang HT; Zheng YY; Wu TT; Hou XG; Jiang ZH; Yang Y; Ma YT; Xie X
Front Cardiovasc Med; 2022; 9():709868. PubMed ID: 35369313
[TBL] [Abstract][Full Text] [Related]
17. Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer.
Song S; Li C; Li S; Gao H; Lan X; Xue Y
Onco Targets Ther; 2017; 10():3145-3154. PubMed ID: 28706446
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.
Chen J; Wei S; Zhao T; Zhang X; Wang Y; Zhang X
Dis Markers; 2022; 2022():7137357. PubMed ID: 35945957
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory response and nutritional biomarkers as predictors of nivolumab efficacy for gastric cancer.
Namikawa T; Yokota K; Tanioka N; Fukudome I; Iwabu J; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Today; 2020 Nov; 50(11):1486-1495. PubMed ID: 32542414
[TBL] [Abstract][Full Text] [Related]
20. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
